Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder

Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder

Abstract Background Polypharmacy is often prescribed for bipolar disorder, yet medication non-adherence remains a serious problem. This study investigated the regularity in the daily dosage taken of mood stabilizers and second generation antipsychotics. Methods Daily self-reported data on medication...

Full description

Bibliographic Details
Main Authors:	Maximilian Pilhatsch, Tasha Glenn, Natalie Rasgon, Martin Alda, Kemal Sagduyu, Paul Grof, Rodrigo Munoz, Wendy Marsh, Scott Monteith, Emanuel Severus, Rita Bauer, Philipp Ritter, Peter C. Whybrow, Michael Bauer
Format:	Article
Language:	English
Published:	SpringerOpen 2018-05-01
Series:	International Journal of Bipolar Disorders
Subjects:	Bipolar disorder Mood stabilizers Second generation antipsychotics Polypharmacy Adherence
Online Access:	http://link.springer.com/article/10.1186/s40345-018-0118-8

Similar Items

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01)

Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers
by: Kyle J. Burghardt, et al.
Published: (2022-02-01)

Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study
by: Ana Aliana Miron, et al.
Published: (2023-01-01)

Combination treatment with second generation antipsychotics other than clozapine
by: C. Schmidt-Kraepelin
Published: (2021-04-01)

Application of Antipsychotic Drugs in Mood Disorders
by: Janusz K. Rybakowski
Published: (2023-02-01)

Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use
by: Eva-Maria Gebauer, et al.
Published: (2022-12-01)

Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning
by: Anne E. Ferrey, et al.
Published: (2018-12-01)

Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients
by: Stine Lassen, et al.
Published: (2023-12-01)

Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics
by: Katerina Kaikoushi, et al.
Published: (2021-09-01)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020-09-01)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
by: Hikaru Hori, et al.
Published: (2022-05-01)

Trajectories of daily antipsychotic use and weight gain in people hospitalized for the first episode of psychosis
by: Kristyna Vochoskova, et al.
Published: (2024-01-01)

Antipsychotic use in patients with schizophrenia treated in private psychiatry
by: C Valterio
Published: (2005-02-01)

Antipsychotic Polypharmacy among Children and Young Adults in Office-Based or Hospital Outpatient Department Settings
by: Minji Sohn, et al.
Published: (2017-11-01)

Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review
by: Amber N. Edinoff, et al.
Published: (2022-03-01)

The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
by: Christian Farrell, et al.
Published: (2020-04-01)

The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization
by: Eric T. Monson, et al.
Published: (2023-11-01)

Antipsychotic prescribing patterns in children and adolescents attending Australian general practice in 2011 and 2017
by: Julie Klau, et al.
Published: (2024-03-01)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
by: Erica A. K. Davis, PharmD, BCPS, BCPP
Published: (2022-01-01)

Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trialsResearch in context
by: Lingzhuo Kong, et al.
Published: (2024-05-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
by: Jari Tiihonen, et al.
Published: (2012-01-01)

Characterising the evolution of antipsychotic polypharmacy and clozapine prescribing patterns in schizophrenia patients during psychiatric hospitalisations
by: J. Lagreula, et al.
Published: (2022-06-01)

Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS)
by: Gabriele Mandarelli, et al.
Published: (2022-02-01)

Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture
by: Tatsuichiro Takahashi, et al.
Published: (2020-09-01)

Antipsychotic Polypharmacy and High Doses in a Rural Portuguese Community Mental Health Service
by: Sara Ramos, et al.
Published: (2021-09-01)

Dosage of antipsychotics in China routine practice
by: T. Zhang, et al.
Published: (2021-04-01)

Associations between the number of antipsychotics prescribed and metabolic parameters in Japanese patients with schizophrenia
by: Yuichiro Watanabe, et al.
Published: (2022-09-01)

Association between benzodiazepine anxiolytic polypharmacy and concomitant psychotropic medications in Japan: a retrospective cross-sectional study
by: Masahiro Takeshima, et al.
Published: (2024-07-01)

Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project
by: Naoki Hashimoto, et al.
Published: (2023-06-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

Medication Dosage Impact on Mortality in Old-Age Individuals with Schizophrenia: A National Cohort Study
by: Jia-Ru Li, et al.
Published: (2024-01-01)

Neutrophil/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs
by: Yali Zheng, et al.
Published: (2024-12-01)

Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
by: Hirotaka Yamagata, et al.
Published: (2024-03-01)

Trends in the multiple prescriptions of hypnotic drugs in a university outpatient in Japan
by: Takao Kato, et al.
Published: (2024-03-01)

An observational study on drug prescribing pattern of psychotropic medication in psychiatry outpatient department of a medical college in Eastern India
by: Ujjwal Bandyopadhyay, et al.
Published: (2023-01-01)

Prescribing trends in treatment-resistant schizophrenia
by: Aynur Görmez, et al.
Published: (2017-10-01)

Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study
by: Amanda J. Wheeler, et al.
Published: (2020-06-01)

Mood Stabilizers of First and Second Generation
by: Janusz K. Rybakowski
Published: (2023-04-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Correlates of severity in a clinical staging model of schizophrenia: a cross-sectional study among 158 subjects
by: Fatima Hamieh, et al.
Published: (2023-09-01)